Company News
Lupin's Philippines Subsidiary Completes Full Buyback
Lupin discloses completion of buyback by Philippine subsidiary Multicare Pharmaceuticals Philippines, Inc. under SEBI Regulation 30.
MPPI bought back remaining 30,559 shares, achieving 100% ownership
